Novel nanostructured biomaterials: implications for coronary stent thrombosis
Varvara Karagkiozaki,1,2 Panagiotis G Karagiannidis,1 Nikolaos Kalfagiannis,1 Paraskevi Kavatzikidou,1 Panagiotis Patsalas,3 Despoina Georgiou,1 Stergios Logothetidis11Lab for Thin Films – Nanosystems and Nanometrology (LTFN), Physics Department, Aristotle University of Thessaloniki, T...
Guardado en:
Autores principales: | Karagkiozaki V, Karagiannidis PG, Kalfagiannis N, Kavatzikidou P, Patsalas P, Georgiou D, Logothetidis S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8fc4a64ccbcb442cab06b0e7a56afe99 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Varvara C Karagkiozaki, et al.
Publicado: (2010) -
Development of a nanoporous and multilayer drug-delivery platform for medical implants
por: Karagkiozaki V, et al.
Publicado: (2012) -
Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning
por: Janjic M, et al.
Publicado: (2017) -
Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
por: Sadeq Tabatabai, et al.
Publicado: (2021) -
Development of “STORE” (stent thrombosis risk evaluation) score to predict stent thrombosis in patients treated with percutaneous coronary intervention for ACS – A study from South India
por: Prayaag Kini, et al.
Publicado: (2021)